The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...

New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need ...

Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing preclinical study of NPM-139 and promising results from the LIBERATE-1 Phase 1 clini ...

Drugs such as Ozempic, Wegovy, and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

The findings of this study suggest that semaglutide was not associated with an increased risk of eye disorders or diabetic retinopathy. Despite the fact that an association between semaglutide ...

Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing ...

Research carried out over the past year has shown a link between using GLP-1 medication for weight loss and a dangerous eye condition that results in sudden vision loss ...

A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with ...

As weight loss drugs like Ozempic and Mounjaro gain a lot of attention worldwide a new study has revealed a rare side effect ...